Trials / Unknown
UnknownNCT00539786
The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD
Clinical Usefulness of Proton Pump Inhibitor Test for Identifying Gastroesophageal Reflux Disease in Patients With Extraesophageal Symptoms
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
PPI test;empirical trial with high-dose proton-pump inhibitors (PPIs) has been shown to be a sensitive tool for diagnosing patients with GERD. However, this diagnostic strategy has not been well established in patients with extraesophageal manifestation of GERD. In this study, we aim to see the relevance of PPI test in diagnosing GERD in patients with extraesophageal symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proton pump inhibitor (rabeprazole) | Patients receives rabeprazole 20mg AM and 20mg PM for 14 days |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2011-04-01
- First posted
- 2007-10-05
- Last updated
- 2014-05-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00539786. Inclusion in this directory is not an endorsement.